Get started
TC.NASDAQBIOILSTC.NASDAQBIOILSTC.NASDAQBIOILS

TC.NASDAQBIOILS

No trades
See on Supercharts
Overview
Analysis
Holdings Discussions Technicals Seasonals

Key stats


Assets under management (AUM)
‪3.78 M‬ ILS
Fund flows (1Y)
‪−959.95 M‬ ILS
Dividend yield (indicated)
—
Discount/Premium to NAV
1.6%
Shares outstanding
‪108.12 K‬
Expense ratio
0.30%

About TC.NASDAQBIOILS


Issuer
MEITAV INV HOUSE
Brand
Tachlit
Home page
tase.co.il
Inception date
Nov 27, 2018
Index tracked
NASDAQ Biotechnology Index
Replication method
Physical
Management style
Passive
Dividend treatment
Capitalizes
Primary advisor
Meitav Mutual Funds Ltd.
ISIN
IL0011448649
The fund's goal try to achieve results as similar as possible to the rate of change in the index of change in the exchange rate of the US dollar.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Exchange-specific
Geography
U.S.
Weighting scheme
Market cap
Selection criteria
NASDAQ - listed

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance——————
NAV total return——————

What's in the fund


As of January 30, 2025
Exposure type
Bonds, Cash & Other
Government
Miscellaneous
Bonds, Cash & Other100.00%
Government59.64%
Miscellaneous31.32%
Cash9.04%
Stock breakdown by region
100%
Middle East100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows